Risk of pancreatitis and pancreatic carcinoma for anti-diabetic medications: findings from real-world safety data analysis and systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Risk of pancreatitis and pancreatic carcinoma for anti-diabetic medications: findings from real-world safety data analysis and systematic review and meta-analysis of randomized controlled trials

Published:2023-11-20 Issue: Volume: Page:1-12
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Muhammed Asif¹,Thomas Christy¹,Kalaiselvan Vivekanandan²,Undela Krishna¹

Affiliation:

1. Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research (NIPER) Guwahati, Kamrup, Assam, India

2. Pharmacovigilance Programme of India (PvPI), National Coordination Centre, Indian Pharmacopoeia Commission, Ghaziabad, Uttar Pradesh, India

Funder

the Institutional Core Grant, NIPER, Guwahati, Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, Government of India

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2023.2284992

Reference41 articles.

1. The Epidemiology of Pancreatitis and Pancreatic Cancer

2. Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies

3. AGA Institute Technical Review on Acute Pancreatitis

4. Acute pancreatitis

5. Updates in drug-induced acute pancreatitis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-functional alpha-cell hyperplasia with glucagon-producing NET: a case report;Frontiers in Endocrinology;2024-09-06

2. Clinical features, treatment, and prognosis of SGLT2 inhibitors induced acute pancreatitis;Expert Opinion on Drug Safety;2024-09-04

3. Ocular adverse events associated with platins: a disproportionality analysis of pharmacovigilance data and extensive systematic review of case reports;Expert Opinion on Drug Safety;2024-08-19

4. Recommendations for the selection of nucleoside analogues as antihuman herpesvirus drugs: a real-world analysis of reported cases from the FDA adverse event reporting system;Expert Opinion on Drug Safety;2024-07-04

5. Risk of acute pancreatitis among new users of empagliflozin compared to sulfonylureas in patients with type 2 diabetes: A post‐authorization safety study;Pharmacoepidemiology and Drug Safety;2024-05